AnaptysBio, Inc. ANAB Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s operating lease right-of-use asset amortization?
- AnaptysBio, Inc. (ANAB) reported operating lease right-of-use asset amortization of $480K in Q1 2026.
- How has AnaptysBio, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- AnaptysBio, Inc.'s operating lease right-of-use asset amortization increased by 4.3% year-over-year, from $460K to $480K.
- What is the long-term trend for AnaptysBio, Inc.'s operating lease right-of-use asset amortization?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s operating lease right-of-use asset amortization has grown at a 6.1% compound annual growth rate (CAGR), from $1.47M to $1.86M.